Anyone else's child get fever and sickness after they got the nasal flu vacc!
Question: How effective is the nasal-spray flu vaccine LAIV (FluMist?)?
In one large study among children aged 15-85 months, the nasal-spray flu vaccine LAIV (FluMist?) reduced the chance of influenza illness by 92% compared with placebo. In a study among adults, the participants were not specifically tested for influenza. However, the study found 19% fewer severe febrile respiratory tract illnesses, 24% fewer respiratory tract illnesses with fever, 23-27% fewer days of illness, 13-28% fewer lost work days, 15-41% fewer health care provider visits, and 43-47% less use of antibiotics compared with placebo.
Who can be vaccinated with the nasal-spray flu vaccine LAIV (FluMist?)?
LAIV (FluMist?) is approved for use in healthy* people 2-49 years of age? who are not pregnant.
Who should not be vaccinated with the nasal-spray flu vaccine LAIV (FluMist?)?
People less than 2 years of age?
People 50 years of age and over
People with a medical condition that places them at high risk for complications from influenza, including those with chronic heart or lung disease, such as asthma or reactive airways disease; people with medical conditions such as diabetes or kidney failure; or people with illnesses that weaken the immune system, or who take medications that can weaken the immune system.
Children <5 years old with a history of recurrent wheezing
Children or adolescents receiving aspirin
People with a history of Guillain-Barr
Answers: How effective is the nasal-spray flu vaccine LAIV (FluMist?)?
In one large study among children aged 15-85 months, the nasal-spray flu vaccine LAIV (FluMist?) reduced the chance of influenza illness by 92% compared with placebo. In a study among adults, the participants were not specifically tested for influenza. However, the study found 19% fewer severe febrile respiratory tract illnesses, 24% fewer respiratory tract illnesses with fever, 23-27% fewer days of illness, 13-28% fewer lost work days, 15-41% fewer health care provider visits, and 43-47% less use of antibiotics compared with placebo.
Who can be vaccinated with the nasal-spray flu vaccine LAIV (FluMist?)?
LAIV (FluMist?) is approved for use in healthy* people 2-49 years of age? who are not pregnant.
Who should not be vaccinated with the nasal-spray flu vaccine LAIV (FluMist?)?
People less than 2 years of age?
People 50 years of age and over
People with a medical condition that places them at high risk for complications from influenza, including those with chronic heart or lung disease, such as asthma or reactive airways disease; people with medical conditions such as diabetes or kidney failure; or people with illnesses that weaken the immune system, or who take medications that can weaken the immune system.
Children <5 years old with a history of recurrent wheezing
Children or adolescents receiving aspirin
People with a history of Guillain-Barr